SLC4A7 and breast cancer: Even though expression of SLC4A7 mRNA was relatively low in basal-like breast cancer, we also observed a significantly worse prognosis (hazard ratio 2.14) for patients with the highest SLC4A7 mRNA levels within this breast cancer subtype (Figure 10G).